Published in J Med Screen on January 01, 1996
The case for strengthening education and training for general practice. Br J Gen Pract (2001) 1.61
Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled. BMJ (1999) 1.28
Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol (2010) 0.90
Estimating the efficacy and efficiency of cascade genetic screening. Am J Hum Genet (2001) 0.90
Hereditary haemochromatosis: never seen a case? Br J Gen Pract (2001) 0.87
Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data. BMC Med Genet (2005) 0.80
Iranian hereditary hemochromatosis patients: baseline characteristics, laboratory data and gene mutations. Med Sci Monit (2012) 0.80
Is genetic screening for hemochromatosis worthwhile? Eur J Epidemiol (2004) 0.76
Screening for haemochromatosis. J Med Screen (1996) 0.75
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med (1999) 11.19
Maternal serum screening for Down's syndrome in early pregnancy. BMJ (1988) 8.65
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. N Engl J Med (1993) 5.56
Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med (1992) 5.21
Is it time for population-based prenatal screening for fragile-X? Lancet (1993) 3.24
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ (1989) 2.96
Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies. Clin Chem (1985) 2.79
Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet (1984) 2.74
Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn (1990) 2.66
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol (1988) 2.62
Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med (1994) 2.56
Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen (2000) 2.47
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol (1988) 2.40
When is it appropriate to apply fetal cell isolation clinically? Am J Obstet Gynecol (1995) 2.17
Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery. Br J Obstet Gynaecol (1991) 1.96
An unsuccessful cotinine-assisted intervention strategy to reduce environmental tobacco smoke exposure during infancy. Am J Dis Child (1992) 1.61
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn (1995) 1.60
Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) (1991) 1.56
Second-trimester serum cotinine levels in nonsmokers in relation to birth weight. Am J Obstet Gynecol (1988) 1.49
The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care (1993) 1.47
Down's syndrome screening with nuchal translucency. Lancet (1997) 1.44
Prenatal screening for open neural-tube defects in Maine. N Engl J Med (1999) 1.42
Rapid detection of neonatal group B streptococcal infections by latex agglutination. J Pediatr (1980) 1.40
Lipoprotein(a) levels in peripheral atherosclerotic disease. J Vasc Surg (1995) 1.39
Why the term "carrier screening" should be abandoned. J Med Screen (1997) 1.39
Maternal serum alpha-fetoprotein, age, and Down syndrome risk. Am J Obstet Gynecol (1987) 1.39
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. J Med Screen (1998) 1.38
Use of serum cotinine to assess the accuracy of self reported non-smoking. Br Med J (Clin Res Ed) (1986) 1.36
Cigarette consumption and serum cotinine in relation to birthweight. Br J Obstet Gynaecol (1987) 1.32
Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands. J Med Screen (1996) 1.29
Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled. BMJ (1999) 1.28
Hereditary haemochromatosis mutation frequencies in the general population. J Med Screen (1998) 1.27
Young maternal age and smoking during pregnancy as risk factors for gastroschisis. Teratology (1993) 1.24
Determination of nicotine and cotinine in human serum and urine: an interlaboratory study. Toxicol Lett (1987) 1.23
Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal (1999) 1.14
Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen (2001) 1.13
Understanding and managing hypernatremic dehydration. Pediatr Clin North Am (1974) 1.11
Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn (1996) 1.11
Self-limited neonatal hyperparathyroidism in familial hypocalciuric hypercalcemia. J Pediatr (1987) 1.09
Prenatal screening for cystic fibrosis. Lancet (1994) 1.07
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clin Chem (1998) 1.06
Environmental tobacco smoke exposure during infancy. Am J Public Health (1990) 1.06
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. Prenat Diagn (1992) 1.05
The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen (2004) 1.05
Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester. Clin Chem (1981) 1.04
The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels. Br J Obstet Gynaecol (1990) 1.00
Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol (1993) 1.00
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia. N Engl J Med (1983) 0.99
Exposure to environmental tobacco smoke measured by cotinine 125I-radioimmunoassay. Clin Chem (1989) 0.99
Ingestion of charcoal lighter fluid. J Pediatr (1975) 0.97
Screening of maternal serum for fetal Down's syndrome in the first trimester. N Engl J Med (1998) 0.97
Maternal serum unconjugated estriol levels are lower in the presence of fetal Down syndrome. Am J Obstet Gynecol (1990) 0.96
Familial congenital disorder resembling stiff-man syndrome. Am J Dis Child (1972) 0.96
Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy. Prenat Diagn (1995) 0.96
Couple screening to avoid thalassemia: successful in Iran and instructive for us. J Med Screen (2005) 0.94
The amnion regulates movement of fetally derived alpha-fetoprotein into maternal blood. J Lab Clin Med (1979) 0.93
Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal (1998) 0.93
An evaluation of analytic goals for assays of drugs: a College of American Pathologists Therapeutic Drug Monitoring Survey Study. Arch Pathol Lab Med (2001) 0.93
Acetylcholinesterase and fetal malformations: modified qualitative technique for diagnosis of neural tube defects. Clin Chem (1981) 0.92
Deregulation of screening for alpha-fetoprotein in pregnancy. N Engl J Med (1984) 0.92
Lipids and lipoproteins in persons with Down's syndrome. J Intellect Disabil Res (1992) 0.92
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia. J Clin Invest (1990) 0.91
Relapse following ampicillin treatment of acute Hemophilus influenzae meningitis. Pediatrics (1968) 0.91
Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8- to 19-year-old age group: a meta-analysis. Pediatrics (1990) 0.91
Maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States: results of a survey. Am J Obstet Gynecol (1990) 0.91
Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am J Med (1982) 0.90
Couple-based prenatal screening for cystic fibrosis in primary care settings. Prenat Diagn (1996) 0.90
Three unusual trisomic patterns in children. Triple X plus triple E-triple X mosaic: normal XY-D trisomy mosaic; partial trisomy with E translocation. Am J Dis Child (1967) 0.89
Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome. J Med Screen (2002) 0.89
Replacing creatinine measurements with specific gravity values to adjust urine cotinine concentrations. Clin Chem (1994) 0.88
Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature. J Clin Lab Anal (1998) 0.87
Self-rated physical activity level during the second trimester and pregnancy outcome. Obstet Gynecol (1991) 0.87
The flow cytometric crossmatch and early renal transplant loss. Transplantation (1990) 0.86